COO vs LLY: fair value comparison
The Cooper Companies, Inc. and Eli Lilly and Company · Updated 2026-08-31
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, LLY currently sits closer to the top of our discount ranking. COO carries the stronger quality grade. COO carries the stronger momentum grade.
| COO | LLY | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $71.17 | $1,174.61 |
| 12-month range | $60.19–$83.92 | $735.19–$1,148.84 |
| Sector rank | #16 of 113 Healthcare | #12 of 113 Healthcare |
| Quality grade | A | D |
| Momentum grade | A | B |
| Leverage | Low | High |
| Margin trend | Stable | Expanding |
| Revenue growth | Modest | High |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Downtrend | — |
| DCF cross-check | Overvalued | — |
| 52-week position | The lower-middle quarter | The top quarter |
Full single-stock breakdowns: COO fair value analysis · LLY fair value analysis